Princeton Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-34
Closed -$3K 251
2019
Q3
$3K Hold
34
﹤0.01% 235
2019
Q2
$3K Hold
34
﹤0.01% 236
2019
Q1
$3K Hold
34
﹤0.01% 226
2018
Q4
$2K Hold
34
﹤0.01% 248
2018
Q3
$3K Hold
34
﹤0.01% 252
2018
Q2
$3K Hold
34
﹤0.01% 282
2018
Q1
$3K Buy
+34
New +$3.26K ﹤0.01% 277
2016
Q4
$843K Sell
7,286
-3,961
-35% -$441K 1.22% 41
2016
Q3
$1.18M Sell
11,247
-1,987
-15% -$215K 1.45% 34
2016
Q2
$1.3M Buy
13,234
+2,170
+20% +$224K 1.49% 40
2016
Q1
$1.11M Buy
11,064
+316
+3% +$32.5K 1.25% 51
2015
Q4
$1.29M Sell
10,748
-406
-4% -$47K 1.45% 37
2015
Q3
$1.21M Sell
11,154
-1,807
-14% -$224K 1.37% 40
2015
Q2
$1.5M Sell
12,961
-825
-6% -$94.3K 1.52% 18
2015
Q1
$1.59M Sell
13,786
-3,138
-19% -$375K 1.55% 18
2014
Q4
$1.89M Sell
16,924
-3,594
-18% -$379K 1.88% 7
2014
Q3
$1.95M Sell
20,518
-2,272
-10% -$205K 1.77% 12
2014
Q2
$1.96M Buy
22,790
+920
+4% +$70K 1.65% 19
2014
Q1
$1.53M Sell
21,870
-570
-3% -$45.1K 1.29% 42
2013
Q4
$1.9M Sell
22,440
-2,094
-9% -$166K 1.57% 17
2013
Q3
$1.89M Sell
24,534
-2,598
-10% -$182K 1.72% 8
2013
Q2
$1.59M Buy
+27,132
New +$1.63M 1.5% 22

Other funds holding CELG

Princeton Capital Management's CELG Position: Q4 2019 in Review

Princeton Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 34 shares — an estimated $3K sold.

Princeton Capital Management first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $1.96M in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Princeton Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Princeton Capital Management sold 34 Celgene Corp shares in Q4 2019, an estimated $3K.
  • Princeton Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Princeton Capital Management's Celgene Corp position peaked at $1.96M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Princeton Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.